News Releases

Select year
Categories

Myriad Genetics Provides Update on Discussions with UnitedHealthcare regarding Medical Policy for Pharmacogenetic Testing

Dec 10, 2024 | Financial

Read more

Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance

Nov 07, 2024 | Products | Financial | Corporate

Read more

Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024

Oct 30, 2024 | Financial

Read more

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

Aug 06, 2024 | Financial | Corporate

Read more

Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024

Jul 30, 2024 | Financial | Corporate

Read more

Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA

May 07, 2024 | Corporate | Financial

Read more

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Apr 30, 2024 | Corporate | Financial

Read more

Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance

Feb 27, 2024 | Financial | Corporate

Read more

Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Feb 21, 2024 | Financial | Corporate

Read more